Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipopolysaccharide (LPS) lipid A phosphate groups are critical anionic components located within the outer membrane of Gram-negative bacteria. These phosphate groups, typically found at the 1 and 4' positions of the lipid A disaccharide backbone, serve as essential binding sites for divalent cations such as magnesium and calcium, which cross-link adjacent LPS molecules to maintain membrane structural integrity and provide a robust permeability barrier. Because of their strong negative charge, these phosphate groups are the primary therapeutic target for cationic polypeptide antibiotics, most notably the polymyxin class, including Polymyxin B and Colistin. When these drugs bind to the phosphate groups, they displace the stabilizing cations, causing a detergent-like disruption of the outer membrane that leads to cell lysis. Beyond their structural role, these groups are central to the endotoxic activity of LPS, triggering potent immune responses through the TLR4/MD-2 complex. Bacterial resistance often arises through the enzymatic modification of these phosphate groups, such as the addition of phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, which reduces the overall negative charge and prevents drug binding.
Cationic antimicrobial peptides like polymyxins bind electrostatically to the anionic phosphate groups of lipid A, displacing stabilizing divalent cations (Mg2+ and Ca2+). This displacement disrupts the integrity of the outer membrane, leading to increased permeability, leakage of cytoplasmic contents, and bacterial cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide lipid A phosphate group (LPS lipid A phosphate).